Abramson D H, Ellsworth R M, Rosenblatt M, Tretter P, Jereb B, Kitchin F D
Arch Ophthalmol. 1982 Aug;100(8):1257-60. doi: 10.1001/archopht.1982.01030040235004.
A retrospective review of cases on file at the Ophthalmic Oncology Center of New York Hospital-Cornell Medical Center, New York, was undertaken to examine the effectiveness of a second course of radiotherapy on retinoblastoma. One hundred four patients were found to have been treated with at least two courses of external beam irradiation to one eye. All but one of the cases were bilateral, the other eye with more advanced disease having been previously enucleated. At the time the decision was made to repeat radiotherapy, 15 eyes could be classified group I, II, or III. Twelve (80%) of these eyes survived. Of the 89 eyes that showed more advanced growth (group IV or V), only two (2.2%) survived. In all, 14 of the 104 eyes wer saved--nine with useful (macula) vision, five without. Second nonocular tumors developed in 18 patients (22.8% of those who survived retinoblastoma itself). There appears to be no increased risk of second tumors from the second course of irradiation.
对纽约医院-康奈尔医学中心眼科肿瘤中心存档病例进行回顾性研究,以检验第二次放疗对视网膜母细胞瘤的疗效。发现104例患者至少接受过两眼的两程外照射治疗。除1例为单侧外,其余均为双侧,另一只眼病情较重,此前已行眼球摘除术。决定重复放疗时,15只眼可分为I、II或III组。其中12只眼(80%)存活。在89只显示更晚期生长的眼(IV或V组)中,仅2只眼(2.2%)存活。104只眼中共有14只眼得以挽救,9只保留有用(黄斑)视力,5只无有用视力。18例患者(视网膜母细胞瘤存活者的22.8%)发生了第二非眼肿瘤。第二次照射似乎并未增加第二肿瘤的风险。